Oncologic Emergencies in Pediatric Critical Care

  • José A. Cortes
  • Rodrigo MejíaEmail author
Reference work entry


Cancer in children is second only to trauma as the cause of death in older children. Approximately 12,000 children and adolescents are diagnosed with cancer annually. Survival rates for some malignancies now surpass 88%. The use of more aggressive treatment modalities to reach these results has been associated with a greater risk for severe life-threatening oncologic emergencies requiring pediatric intensive care (PICU). This chapter focuses on early recognition and treatment of some of the most common and sometimes dramatic presentations of pediatric oncologic emergencies in children with cancer.


Febrile neutropenia Granulocyte colony-stimulating factor Central line-associated bloodstream infection Superior vena cava syndrome (SVCS) Superior mediastinal syndrome Hyperleukocytosis Tumor lysis syndrome Intracranial pressure Septic shock Cardiogenic shock Pediatric intensive care unit 


  1. 1.
    Adler A, Yaniv I, Solter E, Freud E, Samra Z, Stein J, Fisher S, Levy I. Central line-associated bloodstream infections in pediatric hematology-oncology patients: factors associated with catheter removal and recurrence. J Pediatr Hematol Oncol. 2006;28(1):23–8.PubMedGoogle Scholar
  2. 2.
    Anghelescu DL, Burgoyne LL, Liu T, Li CS, Pui CH, Hudson MM, Furman WL, Sandlund JT. Clinical and diagnostic imaging findings predict anesthetic complications in children presenting with malignant mediastinal masses. Paediatr Anaesth. 2007;17(11):1090–8.PubMedPubMedCentralGoogle Scholar
  3. 3.
    Asnani A. Cardiotoxicity of immunotherapy: incidence, diagnosis, and management. Curr Oncol Rep. 2018;20(6):44.PubMedCrossRefGoogle Scholar
  4. 4.
    Bassanezi BS, Oliveira-Filho AG, Miranda ML, Soares L, Aguiar SS. Use of BiPAP for safe anesthesia in a child with a large anterior mediastinal mass. Paediatr Anaesth. 2011;21(9):985–7.PubMedCrossRefGoogle Scholar
  5. 5.
    Bigham MT, Nowak JE, Wheeler DS. Therapeutic application of helium-oxygen and mechanical ventilation in a child with acute myelogenous leukemia and airway obstruction. Pediatr Emerg Care. 2009;25(7):469–72.PubMedCrossRefPubMedCentralGoogle Scholar
  6. 6.
    Borenstein SH, Gerstle T, Malkin D, Thorner P, Filler RM. The effects of prebiopsy corticosteroid treatment on the diagnosis of mediastinal lymphoma. J Pediatr Surg. 2000;35(6):973–6.PubMedCrossRefGoogle Scholar
  7. 7.
    Brandes AA, Tosoni A, Spagnolli F, Frezza G, Leonardi M, Calbucci F, Franceschi E. Disease progression or pseudoprogression after concomitant radiochemotherapy treatment: pitfalls in neurooncology. Neuro-Oncology. 2008;10(3):361–7.PubMedPubMedCentralCrossRefGoogle Scholar
  8. 8.
    Brierley J, Carcillo JA, Choong K, Cornell T, Decaen A, Deymann A, Doctor A, Davis A, Duff J, Dugas MA, Duncan A, Evans B, Feldman J, Felmet K, Fisher G, Frankel L, Jeffries H, Greenwald B, Gutierrez J, Hall M, Han YY, Hanson J, Hazelzet J, Hernan L, Kiff J, Kissoon N, Kon A, Irazuzta J, Lin J, Lorts A, Mariscalco M, Mehta R, Nadel S, Nguyen T, Nicholson C, Peters M, Okhuysen-Cawley R, Poulton T, Relves M, Rodriguez A, Rozenfeld R, Schnitzler E, Shanley T, Kache S, Skippen P, Torres A, von Dessauer B, Weingarten J, Yeh T, Zaritsky A, Stojadinovic B, Zimmerman J, Zuckerberg A. Clinical practice parameters for hemodynamic support of pediatric and neonatal septic shock: 2007 update from the American College of Critical Care Medicine. Crit Care Med. 2009;37(2): 666–88.PubMedPubMedCentralCrossRefGoogle Scholar
  9. 9.
    Cairo MS, Bishop M. Tumour lysis syndrome: new therapeutic strategies and classification. Br J Haematol. 2004;127(1):3–11.PubMedCrossRefPubMedCentralGoogle Scholar
  10. 10.
    Cairo MS, Coiffier B, Reiter A, Younes A, Panel TLSE. Recommendations for the evaluation of risk and prophylaxis of tumour lysis syndrome (TLS) in adults and children with malignant diseases: an expert TLS panel consensus. Br J Haematol. 2010; 149(4):578–86.PubMedCrossRefPubMedCentralGoogle Scholar
  11. 11.
    Cairo MS, Thompson S, Tangirala K, Eaddy MT. A clinical and economic comparison of rasburicase and allopurinol in the treatment of patients with clinical or laboratory tumor lysis syndrome. Clin Lymphoma Myeloma Leuk. 2017;17(3):173–8.PubMedCrossRefPubMedCentralGoogle Scholar
  12. 12.
    Chen K, Wang Q, Pleasants RA, Ge L, Liu W, Peng K, Zhai S. Empiric treatment against invasive fungal diseases in febrile neutropenic patients: a systematic review and network meta-analysis. BMC Infect Dis. 2017;17(1):159.PubMedPubMedCentralCrossRefGoogle Scholar
  13. 13.
    Clark OA, Lyman GH, Castro AA, Clark LG, Djulbegovic B. Colony-stimulating factors for chemotherapy-induced febrile neutropenia: a meta-analysis of randomized controlled trials. J Clin Oncol. 2005;23(18):4198–214.PubMedCrossRefPubMedCentralGoogle Scholar
  14. 14.
    Coiffier B, Altman A, Pui CH, Younes A, Cairo MS. Guidelines for the management of pediatric and adult tumor lysis syndrome: an evidence-based review. J Clin Oncol. 2008;26(16):2767–78.PubMedCrossRefPubMedCentralGoogle Scholar
  15. 15.
    Curtin SC, Minino AM, Anderson RN. Declines in cancer death rates among children and adolescents in the United States, 1999–2014. NCHS Data Brief. 2016;257:1–8.Google Scholar
  16. 16.
    de la Fuente MI, DeAngelis LM. The role of ventriculoperitoneal shunting in patients with supratentorial glioma. Ann Clin Transl Neurol. 2014;1(1):45–8.PubMedCrossRefPubMedCentralGoogle Scholar
  17. 17.
    Duncan CN, Lehmann LE, Cheifetz IM, Greathouse K, Haight AE, Hall MW, Herschberger A, Hill KS, Moffet JR, Morrison RR, Norris AL, Petrovic A, Spear DA, Steiner ME, Talano JA, Tamburro RF, Wagner J, McArthur J, Pediatric Acute Lung I, Sepsis N. Clinical outcomes of children receiving intensive cardiopulmonary support during hematopoietic stem cell transplant. Pediatr Crit Care Med. 2013;14(3):261–7.PubMedCrossRefPubMedCentralGoogle Scholar
  18. 18.
    Efrati O, Sadeh-Gornik U, Modan-Moses D, Barak A, Szeinberg A, Vardi A, Paret G, Toren A, Vilozni D, Yahav Y. Flexible bronchoscopy and bronchoalveolar lavage in pediatric patients with lung disease. Pediatr Crit Care Med. 2009;10(1):80–4.PubMedCrossRefPubMedCentralGoogle Scholar
  19. 19.
    Elbahlawan LM, Avent Y, Montoya L, Wilder K, Pei D, Cheng C, Morrison RR, Jeha S. Safety and benefits of bronchoalveolar lavage and lung biopsy in the management of pulmonary infiltrates in children with leukemia. J Pediatr Hematol Oncol. 2016;38(8): 597–601.PubMedPubMedCentralCrossRefGoogle Scholar
  20. 20.
    Englund J, Feuchtinger T, Ljungman P. Viral infections in immunocompromised patients. Biol Blood Marrow Transplant. 2011;17(1 Suppl):S2–5.PubMedPubMedCentralCrossRefGoogle Scholar
  21. 21.
    Erard V, Guthrie KA, Seo S, Smith J, Huang M, Chien J, Flowers ME, Corey L, Boeckh M. Reduced mortality of cytomegalovirus pneumonia after hematopoietic cell transplantation due to antiviral therapy and changes in transplantation practices. Clin Infect Dis. 2015;61(1):31–9.PubMedPubMedCentralCrossRefGoogle Scholar
  22. 22.
    Fike FB, Mortellaro V, Juang D, St Peter SD, Andrews WS, Snyder CL. Neutropenic colitis in children. J Surg Res. 2011;170(1):73–6.PubMedCrossRefPubMedCentralGoogle Scholar
  23. 23.
    Fletcher M, Hodgkiss H, Zhang S, Browning R, Hadden C, Hoffman T, Winick N, McCavit TL. Prompt administration of antibiotics is associated with improved outcomes in febrile neutropenia in children with cancer. Pediatr Blood Cancer. 2013;60(8): 1299–306.PubMedCrossRefPubMedCentralGoogle Scholar
  24. 24.
    Freifeld AG, Bow EJ, Sepkowitz KA, Boeckh MJ, Ito JI, Mullen CA, Raad II, Rolston KV, Young JA, Wingard JR, A. Infectious Diseases Society of. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of America. Clin Infect Dis. 2011;52(4):e56–93.PubMedCrossRefPubMedCentralGoogle Scholar
  25. 25.
    Gonda DD, Meltzer HS, Crawford JR, Hilfiker ML, Shellington DK, Peterson BM, Levy ML. Complications associated with prolonged hypertonic saline therapy in children with elevated intracranial pressure. Pediatr Crit Care Med. 2013;14(6):610–20.PubMedCrossRefPubMedCentralGoogle Scholar
  26. 26.
    Gun F, Erginel B, Unuvar A, Kebudi R, Salman T, Celik A. Mediastinal masses in children: experience with 120 cases. Pediatr Hematol Oncol. 2012;29(2): 141–7.PubMedCrossRefPubMedCentralGoogle Scholar
  27. 27.
    Howard SC, Jones DP, Pui CH. The tumor lysis syndrome. N Engl J Med. 2011;364(19):1844–54.PubMedPubMedCentralCrossRefGoogle Scholar
  28. 28.
    Inaba H, Pei D, Wolf J, Howard SC, Hayden RT, Go M, Varechtchouk O, Hahn T, Buaboonnam J, Metzger ML, Rubnitz JE, Ribeiro RC, Sandlund JT, Jeha S, Cheng C, Evans WE, Relling MV, Pui CH. Infection-related complications during treatment for childhood acute lymphoblastic leukemia. Ann Oncol. 2017;28(2):386–92.PubMedPubMedCentralGoogle Scholar
  29. 29.
    Khoury NJ, Kanj V, Abboud M, Muwakkit S, Birjawi GA, Haddad MC. Abdominal complications of chemotherapy in pediatric malignancies: imaging findings. Clin Imaging. 2009;33(4):253–60.PubMedCrossRefPubMedCentralGoogle Scholar
  30. 30.
    Kim H, Lee JM, Park JS, Jo SA, Kim YO, Kim CW, Jo I. Dexamethasone coordinately regulates angiopoietin-1 and VEGF: a mechanism of glucocorticoid-induced stabilization of blood-brain barrier. Biochem Biophys Res Commun. 2008; 372(1):243–8.PubMedCrossRefGoogle Scholar
  31. 31.
    Kochanek PM, Carney N, Adelson PD, Ashwal S, Bell MJ, Bratton S, Carson S, Chesnut RM, Ghajar J, Goldstein B, Grant GA, Kissoon N, Peterson K, Selden NR, Tasker RC, Tong KA, Vavilala MS, Wainwright MS, Warden CR, S. American Academy of Pediatrics-Section on Neurological, S. American Association of Neurological Surgeons/Congress of Neurological, S. Child Neurology, P. European Society of, C. Neonatal Intensive, S. Neurocritical Care, G. Pediatric Neurocritical Care Research, M. Society of Critical Care, U. K. Paediatric Intensive Care Society, A. Society for Neuroscience in, C. Critical, I. World Federation of Pediatric, S. Critical Care. Guidelines for the acute medical management of severe traumatic brain injury in infants, children, and adolescents – second edition. Pediatr Crit Care Med. 2012; 13(Suppl 1):S1–82.PubMedGoogle Scholar
  32. 32.
    Lehrnbecher T, Robinson P, Fisher B, Alexander S, Ammann RA, Beauchemin M, Carlesse F, Groll AH, Haeusler GM, Santolaya M, Steinbach WJ, Castagnola E, Davis BL, Dupuis LL, Gaur AH, Tissing WJE, Zaoutis T, Phillips R, Sung L. Guideline for the management of fever and neutropenia in children with cancer and hematopoietic stem-cell transplantation recipients: 2017 update. J Clin Oncol. 2017;35(18):2082–94.PubMedCrossRefGoogle Scholar
  33. 33.
    Liang D, Bhatta S, Gerzanich V, Simard JM. Cytotoxic edema: mechanisms of pathological cell swelling. Neurosurg Focus. 2007;22(5):E2.PubMedPubMedCentralCrossRefGoogle Scholar
  34. 34.
    Lichtman MA, Rowe JM. Hyperleukocytic leukemias: rheological, clinical, and therapeutic considerations. Blood. 1982;60(2):279–83.PubMedCrossRefGoogle Scholar
  35. 35.
    Mahmodlou R, Mohtazeri V, Rahimi-Rad MH, Sekoti M. Mini-mediastinotomy under local anesthesia for biopsy of anterior mediastinal masses with airway compression. Pneumologia. 2011;60(3):143–6.PubMedGoogle Scholar
  36. 36.
    McCrone L, Alexander S, Karsli C, Taylor G, Amaral JG, Parra D, Temple M, John P, Connolly BL. US-guided percutaneous needle biopsy of anterior mediastinal masses in children. Pediatr Radiol. 2012;42(1):40–9.PubMedCrossRefGoogle Scholar
  37. 37.
    Moore AH, Olschowka JA, Williams JP, Paige SL, O’Banion MK. Radiation-induced edema is dependent on cyclooxygenase 2 activity in mouse brain. Radiat Res. 2004;161(2):153–60.PubMedCrossRefGoogle Scholar
  38. 38.
    Moran H, Yaniv I, Ashkenazi S, Schwartz M, Fisher S, Levy I. Risk factors for typhlitis in pediatric patients with cancer. J Pediatr Hematol Oncol. 2009;31(9): 630–4.PubMedCrossRefGoogle Scholar
  39. 39.
    Mortazavi MM, Romeo AK, Deep A, Griessenauer CJ, Shoja MM, Tubbs RS, Fisher W. Hypertonic saline for treating raised intracranial pressure: literature review with meta-analysis. J Neurosurg. 2012;116(1):210–21.PubMedCrossRefGoogle Scholar
  40. 40.
    Muizelaar JP, Wei EP, Kontos HA, Becker DP. Mannitol causes compensatory cerebral vasoconstriction and vasodilation in response to blood viscosity changes. J Neurosurg. 1983;59(5):822–8.PubMedCrossRefPubMedCentralGoogle Scholar
  41. 41.
    Muizelaar JP, Wei EP, Kontos HA, Becker DP. Cerebral blood flow is regulated by changes in blood pressure and in blood viscosity alike. Stroke. 1986;17(1):44–8.PubMedCrossRefPubMedCentralGoogle Scholar
  42. 42.
    Narang S, Harte BH, Body SC. Anesthesia for patients with a mediastinal mass. Anesthesiol Clin N Am. 2001;19(3):559–79.CrossRefGoogle Scholar
  43. 43.
    Nesher L, Rolston KV. Neutropenic enterocolitis, a growing concern in the era of widespread use of aggressive chemotherapy. Clin Infect Dis. 2013; 56(5):711–7.PubMedCrossRefPubMedCentralGoogle Scholar
  44. 44.
    Omuro AM, Lallana EC, Bilsky MH, DeAngelis LM. Ventriculoperitoneal shunt in patients with leptomeningeal metastasis. Neurology. 2005;64(9): 1625–7.PubMedCrossRefPubMedCentralGoogle Scholar
  45. 45.
    Ozdemir MA, Karakukcu M, Patiroglu T, Torun YA, Kose M. Management of hyperleukocytosis and prevention of tumor lysis syndrome with low-dose prednisone continuous infusion in children with acute lymphoblastic leukemia. Acta Haematol. 2009;121(1): 56–62.PubMedCrossRefPubMedCentralGoogle Scholar
  46. 46.
    Pakakasama S, Surayuthpreecha K, Pandee U, Anurathapan U, Maleewan V, Udomsubpayakul U, Butthep P, Santanirand P, Sirachainan N, Hongeng S. Clinical practice guidelines for children with cancer presenting with fever to the emergency room. Pediatr Int. 2011;53(6):902–5.PubMedCrossRefPubMedCentralGoogle Scholar
  47. 47.
    Pancera CF, Hayashi M, Fregnani JH, Negri EM, Deheinzelin D, de Camargo B. Noninvasive ventilation in immunocompromised pediatric patients: eight years of experience in a pediatric oncology intensive care unit. J Pediatr Hematol Oncol. 2008;30(7):533–8.PubMedCrossRefPubMedCentralGoogle Scholar
  48. 48.
    Perger L, Lee EY, Shamberger RC. Management of children and adolescents with a critical airway due to compression by an anterior mediastinal mass. J Pediatr Surg. 2008;43(11):1990–7.PubMedCrossRefPubMedCentralGoogle Scholar
  49. 49.
    Perry A, Schmidt RE. Cancer therapy-associated CNS neuropathology: an update and review of the literature. Acta Neuropathol. 2006;111(3):197–212.PubMedCrossRefPubMedCentralGoogle Scholar
  50. 50.
    Porcu P, Cripe LD, Ng EW, Bhatia S, Danielson CM, Orazi A, McCarthy LJ. Hyperleukocytic leukemias and leukostasis: a review of pathophysiology, clinical presentation and management. Leuk Lymphoma. 2000;39(1–2):1–18.PubMedCrossRefPubMedCentralGoogle Scholar
  51. 51.
    Rinke ML, Chen AR, Bundy DG, Colantuoni E, Fratino L, Drucis KM, Panton SY, Kokoszka M, Budd AP, Milstone AM, Miller MR. Implementation of a central line maintenance care bundle in hospitalized pediatric oncology patients. Pediatrics. 2012; 130(4):e996–e1004.PubMedPubMedCentralCrossRefGoogle Scholar
  52. 52.
    Rowan CM, Gertz SJ, McArthur J, Fitzgerald JC, Nitu ME, Loomis A, Hsing DD, Duncan CN, Mahadeo KM, Smith LS, Moffet J, Hall MW, Pinos EL, Cheifetz IM, Tamburro RF, I. Investigators of the Pediatric Acute Lung, Sepsis N. Invasive mechanical ventilation and mortality in pediatric hematopoietic stem cell transplantation: a multicenter study. Pediatr Crit Care Med. 2016;17(4):294–302.PubMedCrossRefPubMedCentralGoogle Scholar
  53. 53.
    Seth R, Bhat AS. Management of common oncologic emergencies. Indian J Pediatr. 2011;78(6):709–17.PubMedCrossRefPubMedCentralGoogle Scholar
  54. 54.
    Shankar SM, Nania JJ. Management of Pneumocystis jiroveci pneumonia in children receiving chemotherapy. Paediatr Drugs. 2007;9(5):301–9.PubMedCrossRefPubMedCentralGoogle Scholar
  55. 55.
    Singh AK, Sargar K, Restrepo CS. Pediatric mediastinal tumors and tumor-like lesions. Semin Ultrasound CT MR. 2016;37(3):223–37.PubMedCrossRefPubMedCentralGoogle Scholar
  56. 56.
    Stucki A, Rivier AS, Gikic M, Monai N, Schapira M, Spertini O. Endothelial cell activation by myeloblasts: molecular mechanisms of leukostasis and leukemic cell dissemination. Blood. 2001;97(7):2121–9.PubMedCrossRefPubMedCentralGoogle Scholar
  57. 57.
    Sung L, Lange BJ, Gerbing RB, Alonzo TA, Feusner J. Microbiologically documented infections and infection-related mortality in children with acute myeloid leukemia. Blood. 2007;110(10):3532–9.PubMedCrossRefPubMedCentralGoogle Scholar
  58. 58.
    Tsai HC, Huang LM, Chang LY, Lee PI, Chen JM, Shao PL, Hsueh PR, Sheng WH, Chang YC, Lu CY. Central venous central line-associated bloodstream infections in pediatric hematology-oncology patients and effectiveness of antimicrobial lock therapy. J Microbiol Immunol Infect. 2015;48(6):639–46.PubMedCrossRefPubMedCentralGoogle Scholar
  59. 59.
    Xu XJ, Tang YM, Liao C, Song H, Yang SL, Xu WQ, Shi SW, Zhao N. Inflammatory cytokine measurement quickly discriminates gram-negative from gram-positive bacteremia in pediatric hematology/oncology patients with septic shock. Intensive Care Med. 2013;39(2):319–26.PubMedCrossRefPubMedCentralGoogle Scholar
  60. 60.
    Xu XJ, Tang YM, Song H, Yang SL, Xu WQ, Shi SW. Corticosteroid administration is associated with improved outcome of patients presenting high inflammatory cytokine levels during septic shock. Pediatr Blood Cancer. 2014;61(12):2243–8.PubMedCrossRefPubMedCentralGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  1. 1.MD Anderson Cancer CenterHoustonUSA

Section editors and affiliations

  • Rodrigo Mejia
    • 1
  1. 1.Pediatric Critical CareMD Anderson Cancer CenterHoustonUSA

Personalised recommendations